Koyfin Home > Directory > Health Care > Amphastar Pharma > Levered Free Cash Flow (FCF)

Amphastar Pharma Levered Free Cash Flow (FCF) Chart (AMPH)

Amphastar Pharma annual/quarterly Levered Free Cash Flow (FCF) from 2014 to 2018.
  • Amphastar Pharma Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $2m a 389.71% increase of 8m year over year
  • Amphastar Pharma Levered Free Cash Flow (FCF) for the last 12 months ending September 09, 2018 was $-7m a 14.43% decrease of -1m year over year
  • Amphastar Pharma Annual Levered Free Cash Flow (FCF) for 2017 was $-6m a 477.37% decrease of -29m from 2016
  • Amphastar Pharma Annual Levered Free Cash Flow (FCF) for 2016 was $23m a 4.66% increase of 1m from 2015
  • Amphastar Pharma Annual Levered Free Cash Flow (FCF) for 2015 was $22m a 134.56% increase of 29m from 2014
Other Cash Flow Metrics:
  • Amphastar Pharma Cash Flow from Operations for the quarter ending September 09, 2018 was $16m a 38.12% increase of 6m year over year
  • Amphastar Pharma Total Revenue for the quarter ending December 12, 2018 was $90m a 34.89% increase of 31m year over year
View Chart On Koyfin

Quarterly AMPH Levered Free Cash Flow (FCF) Data

09/2018$2m
06/2018$-6m
03/2018$3m
12/2017$-6m
09/2017$-7m
06/2017$-4m
03/2017$11m
12/2016$14m
09/2016$-3m
06/2016$3m

Annual AMPH Levered Free Cash Flow (FCF) Data

2017$-6m
2016$23m
2015$22m
2014$-7m
2013$14m